Cited by 898Thyroid Disorders and TreatmentsThyroid and Parathyroid SurgeryOphthalmology and Eye Disorders

Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists

The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, Rebecca S., Burch, Henry B., Cooper, David S., Garber, Jeffrey R., Greenlee, M. Carol, Klein, Irwin, Laurberg, Peter +6 more·2011·Thyroid

Abstract

BACKGROUND: Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This article describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspeciality physicians and others providing care for patients with this condition. METHODS: The development of these guidelines was commissioned by the American Thyroid Association in association with the American Association of Clinical Endocrinologists. The American Thyroid Association and American Association of Clinical Endocrinologists assembled a task force of expert clinicians who authored this report. The task force examined relevant literature using a systematic PubMed search supplemented with additional published materials. An evidence-based medicine approach that incorporated the knowledge and experience of the panel was used to develop the text and a series of specific recommendations. The strength of the recommendations and the quality of evidence supporting each was rated according to the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation Group. RESULTS: Clinical topics addressed include the initial evaluation and management of thyrotoxicosis; management of Graves' hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery; management of toxic multinodular goiter or toxic adenoma using radioactive iodine or surgery; Graves' disease in children, adolescents, or pregnant patients; subclinical hyperthyroidism; hyperthyroidism in patients with Graves' ophthalmopathy; and management of other miscellaneous causes of thyrotoxicosis. CONCLUSIONS: One hundred evidence-based recommendations were developed to aid in the care of patients with thyrotoxicosis and to share what the task force believes is current, rational, and optimal medical practice.

Integrity signals

Registry

Crossref · 10.1089/thy.2010.0417

Cites

350 of 350 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., Ross, D. S., Sosa, J. A., & Stan, M. N.
Affiliations
  • Mayo Clinic (US)
  • Walter Reed National Military Medical Center (US)
  • Johns Hopkins University (US)
  • Harvard Vanguard Medical Associates (US)
  • Western Slope Endocrinology, Grand Junction, Colorado.
  • North Shore University Hospital (US)
  • Aalborg University Hospital (DK)
  • Stanford Medicine (US)
  • Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
  • Yale University (US)
  • Massachusetts General Hospital (US)
Corresponding author
Bahn, Rebecca S.
Venue
Thyroid
Published
2011-06
Volume
21
Issue
6
Pages
593-646
ISSN
  • 1050-7256 (ISSN-L)
  • 1557-9077
OpenAlex
W3022564440
Cited by
898
References
350
Citations by year
2026: 33 · 2025: 54 · 2024: 37 · 2023: 45 · 2022: 57 · 2021: 54 · 2020: 38 · 2019: 76 · 2018: 46 · 2017: 54 · 2016: 102 · 2015: 79 · 2014: 74 · 2013: 68 · 2012: 65
FWCI
57.73
Type
journal article
Language
en
Open access
closed
Locations
  • Thyroid (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Ophthalmology and Eye Disorders
Keywords
thyrotoxicosis, hyperthyroidism, Graves' disease, Graves' ophthalmopathy, radioactive iodine, antithyroid drugs, thyroid surgery, toxic multinodular goiter, toxic adenoma, subclinical hyperthyroidism, pediatric Graves' disease, treatment guidelines
MeSH terms
Adolescent, Adrenergic beta-Antagonists, Child, Female, Graves Disease, Humans, Hyperthyroidism, Iodine Radioisotopes, Pregnancy, Antithyroid Agents, Thyroid Crisis, Thyroid Hormones, Thyroidectomy, Thyrotoxicosis, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review